Dr. @JLLanciego , principal investigator of the Gene Therapy in Parkinson's Disease group at @CIMA_unav, has been appointed president of the @EUBrainFdn, a leading European organisation for the promotion of research into neurological and mental illnesses.
July 22, 2025 at 6:05 PM
Dr. @JLLanciego , principal investigator of the Gene Therapy in Parkinson's Disease group at @CIMA_unav, has been appointed president of the @EUBrainFdn, a leading European organisation for the promotion of research into neurological and mental illnesses.
Here we review non-human primate models of Parkinson’s disease, with emphasis on the use of adeno-associated viral vectors as tools for disease modeling.
Here we review non-human primate models of Parkinson’s disease, with emphasis on the use of adeno-associated viral vectors as tools for disease modeling.
I am glad to introduce PIGMO, a novel PIGmented MOuse model of Parkinson’s disease, designed for the preclinical testing of disease-modifying therapeutic candidates.
I am glad to introduce PIGMO, a novel PIGmented MOuse model of Parkinson’s disease, designed for the preclinical testing of disease-modifying therapeutic candidates.